3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myeloid, Acute
32
Leukemia, Lymphocytic, Chronic, B-Cell
22
Myelodysplastic Syndromes
9
Lymphoma, Follicular
8
Neoplasms
7
Lymphoma, Non-Hodgkin
7
Lymphoma, Mantle-Cell
7
Precursor Cell Lymphoblastic Leukemia-Lymphoma
6
Leukemia
6
Recurrence
5
Leukemia, Myelomonocytic, Chronic
5
Multiple Myeloma
4
Chromosome 17 deletion
4
Lymphoma, Large B-Cell, Diffuse
3
Lymphoma, B-Cell, Marginal Zone
3
Leukemia, Myeloid
3
Hematologic Neoplasms
3
Waldenstrom Macroglobulinemia
2
Lymphoma, B-Cell
2
Lymphoma
2
Leukemia, Biphenotypic, Acute
2
Breast Neoplasms
2
Tumor Lysis Syndrome
1
Small Cell Lung Carcinoma
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
1
Neuroblastoma
1
Myeloproliferative Disorders
1
Myeloid Malignancy
1
Myeloid Malignancies
1
Interventions
Paclitaxel
96
Carboplatin
81
Bevacizumab
62
Gemcitabine
36
liposomal doxorubicin
32
pembrolizumab
30
Topotecan
26
olaparib
23
Taxes
23
niraparib
17
Immunoglobulin G
17
Disulfides
17
Docetaxel
16
Cyclophosphamide
16
Cisplatin
14
Nivolumab
11
rucaparib
10
durvalumab
10
Doxorubicin
9
Albumin-Bound Paclitaxel
8
sargramostim
7
pazopanib
7
fludarabine phosphate
7
fludarabine
7
avelumab
7
Magnetic Resonance Spectroscopy
7
Ifosfamide
7
epacadostat
6
Trabectedin
6
Sorafenib
6
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Ovarian Neoplasms
×
venetoclax
×
Clear all
No trials found.